+499.5%
MRNA vs KVYO
-39.6%
+539.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | KVYO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -5.8% | +3.6% | -1.7% |
| 7D | +5.5% | -7.6% | +13.1% | +6.3% |
| 30D | +158.7% | -3.6% | +162.3% | +158.4% |
| 3M | +182.1% | +17.9% | +164.2% | +179.5% |
| 6M | +151.8% | -4.7% | +156.5% | +147.0% |
| YTD | +393.6% | -42.7% | +436.2% | +419.8% |
| 1Y | +499.5% | -40.3% | +539.7% | +518.5% |
| All | +499.5% | -39.6% | +539.1% | +518.5% |
Cumulative growth
Daily Returns
Daily percentage return beside KVYO.
Daily Out/Under-Performance
Portfolio return minus KVYO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KVYO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded KVYO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling